Intravenous immunoglobulin: A safe option for treatment of steroid-resistant rejection in the presence of infection

Transplantation

Volumn 77, Issue 9 SUPPL., 2004, Pages 1455-1456

  Moger, Venkatesh ^a   Ravishankar, Machiraju S ^a   Sakhuja, Vinay ^a   Kohli, Harbir S ^a   Sud, Kamal ^a   Gupta, Krishan L ^a   Jha, Vivekanand ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; AZATHIOPRINE; CREATININE; CYCLOSPORIN A; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISOLONE; STEROID;

ADULT; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; ESCHERICHIA COLI; GRAFT INFECTION; GRAFT SURVIVAL; HERPES ZOSTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INFECTION RISK; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; PRIORITY JOURNAL; URINARY TRACT INFECTION;

ADULT; CYTOMEGALOVIRUS INFECTIONS; DRUG RESISTANCE; ESCHERICHIA COLI INFECTIONS; GRAFT REJECTION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY TRANSPLANTATION; MALE; STEROIDS;

EID: 2442677763     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000122415.08639.53     Document Type: Article

References (10)

1. Rocha PN, Butterly DW, Greenberg A, et al. Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. Transplantation 2003; 75: 1490.
2. Luke PP, Scantleberg VP, Jordan ML, et al. Reversal of steroid and antilymphocyte antibody resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipients. Transplantation 2001; 72: 419.
3. Casadei DH, Rial MDC, Opelz G, et al. A randomized and prospective study comparing treatment with high dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid resistant rejection. Transplantation 2001; 71: 53.
4. Dwyer JM. Intravenous therapy with gamma globulins. Adv Intern Med 1987; 32: 111.
5. Al-Uzri AY, Seltz B, Yorgin PD, et al. Successful renal transplant outcome after intravenous gamma globulin treatment of a highly sensitized pediatric patient. Pediatric Transplant 2002; 6: 161.
6. Peraldi MN, Akposso K, Hayman JP, et al. Long term benefit of intravenous immunoglobulin in cadaveric kidney retransplantation. Transplantation 1996; 62: 1670.
7. Guglielmo BJ, Wong Beringer A, Linker CA. Immune globulin therapy in allogeneic bone marrow transplant: a critical review. Bone Marrow Transplant 1994; 13: 499.
8. Buckley RH, Schiff RJ. Use of intravenous immunoglobulin in immunodeficiency diseases. N Engl J Med 1991; 325: 110.
9. Marchalonis JJ, Kaymaz H, Dedeoglu F, et al. Human autoantibodies reactive with synthetic auto-antigens from T-cell receptor beta chain. Proc Natl Acad Sci USA 1992; 89: 3325.
10. Tsinalis D, Dickenmann M, Brunner F, et al. Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin. Am J Kidney Dis 2002; 40: 667.